Sveriges mest populära poddar

OPKO's Bishop on FDA Approval Of Its Kidney Disease Drug(Audio)

8 min•30 juni 2016

Om avsnittet

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding chronic kidney disease

See omnystudio.com/listener for privacy information.

Fler avsnitt

What The Bond Selloff Means For Your Wallet & Simplifying Finance For Your Family

26 sep.48 min

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013

25 sep.18 min

Meta Introduces Palm-Sized Device to Use Muse AI

24 sep.19 min

Disney+ Price to Jump 13% to $21.49 Per Month

23 sep.22 min

Meta’s New Muse AI App Makes Shopping Easier

22 sep.17 min

Paramount to Settle Lawsuits Against WBD Deal

21 sep.19 min

The Bank of Mom & Dad; College Sports Going Pro & The Return of the Suit

19 sep.44 min

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.